The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.
Open accessAbstract
The optimal clinical management of patients with antiphospholipid antibody syndrome (APS) is uncertain because of a lack of an underlying hypothesis to explain why antiphospholipid autoantibodies (aPL) form to such ubiquitous compounds as phospholipids (PL). In this paper, we demonstrate that many, if not most, aPL are actually directed at neoepitopes of oxidized PL, or neoepitopes generated by adduct formation between breakdown products of oxidized PL and associated proteins. Each cardiolipin (CL) molecule contains four unsaturated fatty acids and is highly susceptible to oxidation, particularly upon exposure to air. Yet, standard anticardiolipin antibodies (aCL) immunoassays routinely bind CL to microtiter wells by evaporation of the ethanol solvent overnight at 4 degrees C. Using a variety of techniques, we demonstrated that rapid oxidation occurs when CL is plated and exposed to air. Sera from apo E-deficient mice, which have high autoantibody titers to oxidized low density lipoprotein, showed a striking time-dependent increase in binding to CL that was exposed to air for increasing periods of time. Monoclonal antibodies to oxidized LDL, cloned from the apo E-deficient mice, also bound to oxidized CL. Both sera and affinity-purified aCL-IgG from APS patients bound to CL progressively as it was oxidized. However, the monoclonal antibodies from apo E-deficient mice, or sera or aCL-IgG from APS patients did not bind to a reduced CL analog that was unable to undergo peroxidation. These data demonstrate that many aPL are directed at neoepitopes of oxidized phospholipids, and suggest that oxidative events may be important in the pathophysiology of APS. In turn, this suggests new therapeutic strategies, possibly including intensive antioxidant therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
Self-citationRole of oxidized low density lipoprotein in atherogenesis.
Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,675
Self-citationAtherosclerosis: Basic Mechanisms: Oxidation, Inflammation, and Genetics
Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards, P. A., Watson, A. D., & Lusis, A. J. (1995) · Circulation · doi:10.1161/01.cir.91.9.2488 · Cited by 1,701
Steinbrecher, U. P., Parthasarathy, S., Leake, D. S., Witztum, J. L., & Steinberg, D. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.12.3883 · Cited by 1,626
Self-citationMcNeil, H. P., Simpson, R. J., Chesterman, C. N., & Krilis, S. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4120 · Cited by 1,595
Low density lipoprotein undergoes oxidative modification in vivo.
Palinski, W., Rosenfeld, M. E., Ylä-Herttuala, S., Gurtner, G. C., Socher, S. S., Butler, S. W., Parthasarathy, S., Carew, T. E., Steinberg, D., & Witztum, J. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1372 · Cited by 1,519
Self-citationThe management of thrombosis in the antiphospholipid-antibody syndrome
Khamashta, M. A., Cuadrado, M. J., Mujic, F., Taub, N. A., Hunt, B. J., & Hughes, G. R. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321504 · Cited by 1,450
The oxidation hypothesis of atherosclerosis
Witztum, J. L. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92346-9 · Cited by 1,389
Self-citationYan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
Galli, M., Barbui, T., Comfurius, P., Maassen, C., Hemker, H. C., Zwaal, R. F. A., Bevers, E. M., de Baets, M. H., & van Breda-Vriesman, P. J. C. (1990) · The Lancet · doi:10.1016/0140-6736(90)91374-j · Cited by 1,270
Love, P. E., & Santoro, S. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-682 · Cited by 1,095
The "primary" antiphospholipid syndrome: major clinical and serological features.
Asherson, R. A., Khamashta, M. A., Ordi‐Ros, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · PubMed · Cited by 892
Malondialdehyde-Altered Protein Occurs in Atheroma of Watanabe Heritable Hyperlipidemic Rabbits
Haberland, M. E., Fong, D., & Cheng, L. (1988) · Science · doi:10.1126/science.2455346 · Cited by 748
Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.
Libby, P., & Hansson, G. K. (1991) · PubMed · Cited by 663
ALARCÓN-SEGOVIA, D., DELEZÉ, M., ORIA, C. V., SÁNCHEZ-GUERRERO, J., GÓMEZ-PACHECO, L., CABIEDES, J., FERNÁNDEZ, L., & DE LEÓN, S. P. (1989) · Medicine · doi:10.1097/00005792-198911000-00003 · Cited by 639
Palinski, W., Ylä-Herttuala, S., Rosenfeld, M. E., Butler, S. W., Socher, S. A., Parthasarathy, S., Curtiss, L. K., & Witztum, J. L. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.3.325 · Cited by 616
Self-citationPalinski, W., Hörkkö, S., Miller, E., Steinbrecher, U. P., Powell, H. C., Curtiss, L. K., & Witztum, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118853 · Cited by 559
Self-citationMatsuura, E., Igarashi, Y., Yasuda, T., Triplett, D. A., & Koike, T. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.457 · Cited by 529
Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis
Ginsburg, K. S., Liang, M. H., Newcomer, L., Goldhaber, S. Z., Schur, P. H., Hennekens, C. H., & Stampfer, M. J. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-997 · Cited by 526
Palinski, W., Ord, V. A., Plump, A. S., Breslow, J. L., Steinberg, D., & Witztum, J. L. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.4.605 · Cited by 488
Self-citationLipid peroxidation in pregnancy: New perspectives on preeclampsia
Hubel, C. A., Roberts, J. M., Taylor, R. N., Musci, T. J., Rogers, G. M., & McLaughlin, M. K. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90778-3 · Cited by 445
(1992) · PubMed · Cited by 434
Harris, E. N. (1990) · American Journal of Clinical Pathology · doi:10.1093/ajcp/94.4.476 · Cited by 414
Vaarala, O., Aho, K., Palosuo, T., Alfthan, G., Jauhiainen, M., & Leirisalo-Repo, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)91213-6 · Cited by 409
Watson, A. D., Navab, M., Hama, S. Y., Sevanian, A., Prescott, S. M., Stafforini, D. M., McIntyre, T. M., Du, B. N., Fogelman, A. M., & Berliner, J. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117726 · Cited by 403
Parthasarathy, S., Steinbrecher, U. P., Barnett, J., Witztum, J. L., & Steinberg, D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.9.3000 · Cited by 378
Self-citationReaven, P., Parthasarathy, S., Grasse, B. J., Miller, E., Steinberg, D., & Witztum, J. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116247 · Cited by 374
Self-citationHamsten, A., Björkholm, M., Norberg, R., De Faire, U., & Holm, G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92258-0 · Cited by 356
Asherson, R. A., Khamashta, M. A., Gil, A., Vazquez, J.-J., Chan, O., Baguley, E., & Hughes, G. R. V. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90335-5 · Cited by 330
Vaarala, O., Mänttäri, M., Manninen, V., Tenkanen, L., Puurunen, M., Aho, K., & Palosuo, T. (1995) · Circulation · doi:10.1161/01.cir.91.1.23 · Cited by 317
Heery, J. M., Kozak, M., Stafforini, D. M., Jones, D. A., Zimmerman, G. A., McIntyre, T. M., & Prescott, S. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118288 · Cited by 306
OutiVaarala, MattiMänttäri, VesaManninen, LeenaTenkanen, MarjaPuurunen, KimmoAho, & TimoPalosuo (1995) · Circulation · Cited by 305
Role of oxidized low density lipoprotein in atherogenesis
Parthasarathy, S., & Rankin, S. M. (1992) · Progress in Lipid Research · doi:10.1016/0163-7827(92)90006-5 · Cited by 290
Sheppard, B. L., & Bonnar, J. (1981) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1981.tb01268.x · Cited by 284
Itabe, H., Takeshima, E., Iwasaki, H., Kimura, J., Yoshida, Y., Imanaka, T., & Takano, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36602-4 · Cited by 282
Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease.
Holvoet, P., Perez, G., Zhao, Z., Brouwers, E., Bernar, H., & Collen, D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117963 · Cited by 262
Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload.
Houglum, K., Filip, M., Witztum, J. L., & Chojkier, M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114934 · Cited by 254
Self-citationOxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases.
Bashir, S., Harris, G., Denman, M. A., Blake, D. R., & Winyard, P. G. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.9.659 · Cited by 250
Boyd, H. C., Gown, A. M., Wolfbauer, G., & Chait, A. (1989) · PubMed Central · Cited by 244
Anticardiolipin response in acute infections
Vaarala, O., Palosuo, T., Kleemola, M., & Aho, K. (1986) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(86)90046-2 · Cited by 231
Stremler, K. E., Stafforini, D. M., Prescott, S. M., Zimmerman, G. A., & McIntyre, T. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83548-7 · Cited by 227
Gharavi, A. E., Sammaritano, L. R., Wen, J., & Elkon, K. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115927 · Cited by 203
Anticardiolipin antibodies in NZW x BXSB F1 mice. A model of antiphospholipid syndrome
Hashimoto, Y., Kawamura, M., Ichikawa, K., Suzuki, T., Sumida, T., Yoshida, S., Matsuura, E., Ikehara, S., & Koike, T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.3.1063 · Cited by 186
Complete nucleotide and deduced amino acid sequence of human β 2-glycoprotein I
Steinkasserer, A., Estaller, C., Weiss, E. H., Sim, R. B., & Day, A. J. (1991) · Biochemical Journal · doi:10.1042/bj2770387 · Cited by 181
Steinbrecher, U. P., Fisher, M., Witztum, J. L., & Curtiss, L. K. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37720-8 · Cited by 175
Self-citationCORONARY ARTERY BYPASS GRAFT FAILURE—AN AUTOIMMUNE PHENOMENON?
Morton, K., Krilis, S. A., Baron, D., Gavaghan, T. P., Daggard, G. E., Jb, H., & Chesterman, C. N. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92004-0 · Cited by 147
Neale, T. J., Ojha, P. P., Exner, M., et al. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117499 · Cited by 144
Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein
Branch, D. W., Mitchell, M. D., Miller, E. R., Palinski, W., & Witztum, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92639-5 · Cited by 139
Self-citation(1994) · PubMed · Cited by 116
Atherosclerosis: Basic mechanisms: Oxidation, inflammation, and genetics
Berliner, J. A. (1996) · ACC Current Journal Review · doi:10.1016/1062-1458(96)86717-1 · Cited by 116
Anticardiolipin Wet Workshop Report:Fifth International Symposium on Antiphospholipid Antibodies
Harris, E. N., Pierangeli, S. S., & Birch, D. (1994) · American Journal of Clinical Pathology · doi:10.1093/ajcp/101.5.616 · Cited by 115
Self-citationInterlaboratory variation in antiphospholipid antibody testing
Peaceman, A. M., Silver, R. K., MacGregor, S. N., & Socol, M. L. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91569-v · Cited by 108
Isolation and Characterization of Human Antioxidized LDL Autoantibodies
Mironova, M., Virella, G., & Lopes-Virella, M. F. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.2.222 · Cited by 97
Rauch, J., & Janoff, A. S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4112 · Cited by 93
Swartz, G. M., Gentry, M. K., Amende, L. M., Blanchette‐Mackie, E. J., & Alving, C. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.6.1902 · Cited by 93
Pierangeli, S. S., Harris, E. N., Davis, S. A., & DeLorenzo, G. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb06468.x · Cited by 92
Self-citationHammer, A., Kager, G., Dohr, G., Rabl, H., Ghassempur, I., & Jürgens, G. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.5.704 · Cited by 78
Antibodies to liposomes, phospholipids and phosphate esters
Alving, C. R. (1986) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(86)90075-7 · Cited by 71
Anti-cardiolipin antibodies in ischaemic heart disease.
Klemp, P., Cooper, R., Strauss, F. J., Jordaan, E., Przybojewski, J. Z., & Nel, N. (1988) · PubMed Central · Cited by 69
Lipoperoxides in LDL incubated with fibroblasts that overexpress 15-lipoxygenase.
Ezaki, M., Witztum, J. L., & Steinberg, D. H. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41117-4 · Cited by 64
Self-citationAutoantibodies to malondialdehyde-modified epitope in connective tissue diseases and vasculitides
Amara, A., Constans, J., Chaugier, C., Sebban, A., Dubourg, L. D., Peuchant, E., Pellegrin, J., Leng, B., Conri, C., & Geffard, M. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb08344.x · Cited by 55
Antiphospholipid antibodies and the antiphospholipid syndrome
Harris, E. N., & Pierangeli, S. S. (1994) · Springer Seminars in Immunopathology · doi:10.1007/bf00197519 · Cited by 55
Self-citationMizutani, H., Kurata, Y., Kosugi, S., Shiraga, M., Kashiwagi, H., Tomiyama, Y., Kanakura, Y., Good, R. A., & Matsuzawa, Y. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780381005 · Cited by 45
Recognition of oxidized DNA bases by sera of patients with inflammatory diseases
Frenkel, K., Karkoszka, J., Kim, E. Y., & Taioli, E. (1993) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(93)90105-4 · Cited by 43
Thrombosis in the Antiphospholipid-Antibody Syndrome
Violi, F., Ferro, D., & Valesini, G. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331016 · Cited by 37
Are immunoglobulins with lupus anticoagulant activity specific for phospholipids?
Pierangeli, S. S., Harris, E. N., Gharavi, A. E., Goldsmith, G., Branch, D. W., & Dean, W. L. (1993) · British Journal of Haematology · doi:10.1111/j.1365-2141.1993.tb08655.x · Cited by 30
Self-citationAnticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis
&NA; (1993) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-199309000-00006 · Cited by 29
Fatty acid chain is a critical epitope for antiphospholipid antibody
Levy, R. A., Gharavi, A. E., Sammaritano, L. R., Habina, L., & Lockshin, M. D. (1990) · Journal of Clinical Immunology · doi:10.1007/bf00917913 · Cited by 28
Hopewell, P. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331017 · Cited by 10
The preparation of a sensitive partial thromboplastin reagent from bovine brain
Martin, B. A., Branch, D. W., & Rodgers, G. M. (1992) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199206000-00008 · Cited by 7
Self-citationAntiphospholipid antibodies and the antiphospholipid syndrome
Harris, E. N., & Pierangeli, S. S. (1995) · Springer eBooks · doi:10.1007/978-3-642-79622-7_7 · Cited by 4
Self-citation
Cited by
Low Density Lipoprotein Oxidation and Its Pathobiological Significance
Steinberg, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.20963 · Cited by 1,642
Levine, J. S., Branch, D. W., & Rauch, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmra002974 · Cited by 1,543
Self-citationNapoli, C., D'Armiento, F. P., Mancini, F. P., Postiglione, A., Witztum, J. L., Palumbo, G., & Palinski, W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119813 · Cited by 1,014
Self-citationImmune Mechanisms in Atherosclerosis
Hansson, G. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1201.100220 · Cited by 876
A lipid associated with the antiphospholipid syndrome regulates endosome structure and function
Kobayashi, T., Stang, E., Fang, K. S., de Moerloose, P., Parton, R. G., & Gruenberg, J. (1998) · Nature · doi:10.1038/32440 · Cited by 787
Metadata
- Authors
- Hörkkö, S., Miller, E., Dudl, E., Reaven, P., Curtiss, L. K., Zvaifler, N. J., Terkeltaub, R., Pierangeli, S. S., Branch, D. W., Palinski, W., & Witztum, J. L.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-08-01
- Volume
- 98
- Issue
- 3
- Pages
- 815-825
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2078816959
- Cited by
- 348
- References
- 71
- FWCI
- 24.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.